Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Bacterial Infections and Mycoses

  Free Subscription


28.06.2021

4 Am J Med
77 Antimicrob Agents Chemother
1 BMC Neurol
2 BMJ
13 Clin Infect Dis
3 Curr Microbiol
1 Diagn Microbiol Infect Dis
1 Eur J Clin Microbiol Infect Dis
1 Infect Immun
45 J Antimicrob Chemother
1 J Bacteriol
12 J Clin Microbiol
1 J Immunol
1 J Infect Dis
5 J Med Chem
1 JAMA
1 MMWR Morb Mortal Wkly Rep
3 N Engl J Med
1 Nat Med
1 Nature
18 PLoS Negl Trop Dis
16 PLoS One
14 PLoS Pathog
1 Proc Natl Acad Sci U S A
1 Science


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Med

  1. PERAVALI R, Muddassir K
    A Rare but Fatal Waterborne Infection.
    Am J Med. 2021;134:e329-e330.
    PubMed        

  2. CARE W, Picard BH, Alby-Laurent F, Lazareth H, et al
    Swelling of a Finger in a Renal Transplant Recipient.
    Am J Med. 2021;134:e384-e385.
    PubMed        

  3. ALABI FO, Lama ME, Alabi CO, Cordero-Gomez AN, et al
    A Case of Bone-Eroding Mycobacterium avium Complex Infection Secondary to Prolonged Infliximab Use.
    Am J Med. 2021;134:e386-e387.
    PubMed        

  4. IVERSEN DB, Hellfritzsch M, Stage TB, Aabenhus RM, et al
    Antimycotic Treatment of Oral Candidiasis in Warfarin Users.
    Am J Med. 2021;134:e308-e312.
    PubMed         Abstract available


    Antimicrob Agents Chemother

  5. WAN M, Gao X, Lv L, Cai Z, et al
    IS26 Mediates the Acquisition of Tigecycline Resistance Gene Cluster tmexCD1-toprJ1 by IncHI1B-FIB Plasmids in Klebsiella pneumoniae and Klebsiella quasipneumoniae from Food Market Sewage.
    Antimicrob Agents Chemother. 2021;65.
    PubMed        

  6. BROWN-ELLIOTT BA, Wallace RJ Jr
    In Vitro Susceptibility Testing of Omadacycline against Nontuberculous Mycobacteria.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  7. KAWAGUCHI N, Katsube T, Echols R, Wajima T, et al
    Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Patients with Pneumonia, Bloodstream Infection/Sepsis, or Complicated Urinary Tract Infection.
    Antimicrob Agents Chemother. 2020 Nov 30. pii: AAC.01437.
    PubMed         Abstract available

  8. MOTA FERNANDES C, Dasilva D, Haranahalli K, McCarthy JB, et al
    The Future of Antifungal Drug Therapy: Novel Compounds and Targets.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  9. FOURNIER D, Carriere R, Bour M, Grisot E, et al
    Mechanisms of Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa: Results of the GERPA Multicenter Study.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  10. HE R, Yang Y, Wu Y, Zhong LL, et al
    Characterization of a Plasmid-Encoded Resistance-Nodulation-Division Efflux Pump in Klebsiella pneumoniae and Klebsiella quasipneumoniae from Patients in China.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  11. DRUSANO GL, Kim S, Almoslem M, Schmidt S, et al
    The Funnel: a Screening Technique for Identifying Optimal Two-Drug Combination Chemotherapy Regimens.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  12. PYBUS CA, Felder-Scott C, Obuekwe V, Greenberg DE, et al
    Cefiderocol Retains Antibiofilm Activity in Multidrug-Resistant Gram-Negative Pathogens.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  13. FANG Y, Kirsch JR, Li L, Brooks SA, et al
    Deimmunized Lysostaphin Synergizes with Small-Molecule Chemotherapies and Resensitizes Methicillin-Resistant Staphylococcus aureus to beta-Lactam Antibiotics.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  14. LUO P, Huang Y, Hang X, Tong Q, et al
    Dihydrotanshinone I Is Effective against Drug-Resistant Helicobacter pylori In Vitro and In Vivo.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  15. BEGANOVIC M, Daffinee KE, Luther MK, LaPlante KL, et al
    Minocycline Alone and in Combination with Polymyxin B, Meropenem, and Sulbactam against Carbapenem-Susceptible and -Resistant Acinetobacter baumannii in an In Vitro Pharmacodynamic Model.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  16. KEATING CL, Zuckerman JB, Singh PK, McKevitt M, et al
    Pseudomonas aeruginosa Susceptibility Patterns and Associated Clinical Outcomes in People with Cystic Fibrosis following Approval of Aztreonam Lysine for Inhalation.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  17. SCHAFLE D, Selchow P, Borer B, Meuli M, et al
    Rifabutin Is Inactivated by Mycobacterium abscessus Arr.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  18. LE W, Su X, Lou X, Li X, et al
    Susceptibility Trends of Zoliflodacin against Multidrug-Resistant Neisseria gonorrhoeae Clinical Isolates in Nanjing, China, 2014 to 2018.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  19. FRANCISCO EC, de Almeida Junior JN, Queiroz-Telles F, Aquino VR, et al
    Correlation of Trichosporon asahii Genotypes with Anatomical Sites and Antifungal Susceptibility Profiles: Data Analyses from 284 Isolates Collected in the Last 22 Years across 24 Medical Centers.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  20. PAPP-WALLACE KM, Shapiro AB, Becka SA, Zeiser ET, et al
    In Vitro Antibacterial Activity and In Vivo Efficacy of Sulbactam-Durlobactam against Pathogenic Burkholderia Species.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  21. POT M, Guyomard-Rabenirina S, Couvin D, Ducat C, et al
    Dissemination of Extended-Spectrum-beta-Lactamase-Producing Enterobacter cloacae Complex from a Hospital to the Nearby Environment in Guadeloupe (French West Indies): ST114 Lineage Coding for a Successful IncHI2/ST1 Plasmid.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  22. BOONSTRA JM, Martson AG, Sandaradura I, Kosterink JGW, et al
    Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill Patients.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  23. LEE J, Ammerman N, Agarwal A, Naji M, et al
    Differential In Vitro Activities of Individual Drugs and Bedaquiline-Rifabutin Combinations against Actively Multiplying and Nutrient-Starved Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  24. BERNET E, Lebughe M, Vincent AT, Haghdoost MM, et al
    Sodium Tetraphenylborate Displays Selective Bactericidal Activity against Neisseria meningitidis and N. gonorrhoeae and Is Effective at Reducing Bacterial Infection Load.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  25. YANG T, Pan L, Wu N, Wang L, et al
    Antimicrobial resistance in clinical Ureaplasma spp. and Mycoplasma hominis and structural mechanisms underlying the quinolone resistance.
    Antimicrob Agents Chemother. 2020 Mar 30. pii: AAC.02560.
    PubMed         Abstract available

  26. SHIRAKAWA T, Sekizuka T, Kuroda M, Suzuki S, et al
    Comparative Genomic Analysis of Third Generation Cephalosporin-Resistant Escherichia coli Harboring bla CMY-2-Positive IncI1 group, IncB/O/K/Z, and IncC Plasmids Isolated from Healthy Broilers in Japan.
    Antimicrob Agents Chemother. 2020 May 4. pii: AAC.02385.
    PubMed         Abstract available

  27. PARMAR NR, Singh R, Martin I, Perera SR, et al
    Genomic Analysis Reveals Antibiotic Susceptible Clones and Emerging Resistance in Neisseria gonorrhoeae (Saskatchewan, Canada).
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.02514.
    PubMed         Abstract available

  28. HAO M, He Y, Zhang H, Liao XP, et al
    CRISPR/Cas9-mediated carbapenemase genes and plasmids curing in carbapenem-resistant Enterobacteriaceae.
    Antimicrob Agents Chemother. 2020 Jul 6. pii: AAC.00843.
    PubMed         Abstract available

  29. STAPLETON AE, Wagenlehner FME, Mulgirigama A, Twynholm M, et al
    E. coli Resistance to Fluoroquinolones in Community-Acquired Uncomplicated Urinary Tract Infection In Women: A Systematic Review.
    Antimicrob Agents Chemother. 2020 Aug 3. pii: AAC.00862.
    PubMed         Abstract available

  30. SKIPPER C, Atukunda M, Stadelman A, Engen N, et al
    Safety and tolerability of a novel oral formulation of amphotericin B: Phase I EnACT Trial.
    Antimicrob Agents Chemother. 2020 Aug 3. pii: AAC.00838.
    PubMed         Abstract available

  31. PEIRANO G, Chen L, Kreiswirth BN, Pitout JDD, et al
    Emerging Antimicrobial Resistant High-Risk clones among Klebsiella pneumoniae: ST307 and ST147.
    Antimicrob Agents Chemother. 2020 Aug 3. pii: AAC.01148.
    PubMed         Abstract available

  32. ADAMOWICZ EM, Harcombe WR
    Weakest link dynamics predict apparent antibiotic interactions in a model cross-feeding community.
    Antimicrob Agents Chemother. 2020 Aug 10. pii: AAC.00465.
    PubMed         Abstract available

  33. HAGMANN SHF, Angelo KM, Huits R, Plewes K, et al
    Epidemiological, and Clinical Characteristics of International Travelers with Enteric Fever and Antibiotic Resistance Profiles of their Isolates: A GeoSentinel Analysis.
    Antimicrob Agents Chemother. 2020 Aug 17. pii: AAC.01084.
    PubMed         Abstract available

  34. MADUNA LD, Kock MM, van der Veer BMJW, Radebe O, et al
    Antimicrobial resistance of Neisseria gonorrhoeae isolates from high risk men in Johannesburg, South Africa.
    Antimicrob Agents Chemother. 2020 Aug 31. pii: AAC.00906.
    PubMed         Abstract available

  35. NESPOROVA K, Wyrsch ER, Valcek A, Bitar I, et al
    Escherichia coli ST457: an emerging extended-spectrum beta-lactam resistant lineage with reservoirs in wildlife and food-producing animals.
    Antimicrob Agents Chemother. 2020 Oct 5. pii: AAC.01118.
    PubMed         Abstract available

  36. BARBEE LA, Soge OO, Ocbamichael N, LeClair A, et al
    A Single-arm Open-label Clinical Trial of 2g Aztreonam for the treatment of N. gonorrhoeae.
    Antimicrob Agents Chemother. 2020 Oct 19. pii: AAC.01739.
    PubMed         Abstract available

  37. JAKOBSEN L, Vingsbro Lundberg C, Frimodt-Moller N
    Ciprofloxacin pharmacokinetics/pharmacodynamics (PKPD) against susceptible and low level resistant Escherichia coli in an experimental ascending urinary tract infection model in mice.
    Antimicrob Agents Chemother. 2020 Oct 26. pii: AAC.01804.
    PubMed         Abstract available

  38. CAVENEY NA, Serapio-Palacios A, Woodward SE, Bozorgmehr T, et al
    Structural and Cellular Insights into the l,d-Transpeptidase YcbB as a Therapeutic Target in Citrobacter rodentium, Salmonella Typhimurium, and Salmonella Typhi Infections.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  39. PHAM CD, Nash E, Liu H, Schmerer MW, et al
    Atypical Mutation in Neisseria gonorrhoeae 23S rRNA Associated with High-Level Azithromycin Resistance.
    Antimicrob Agents Chemother. 2020 Nov 2. pii: AAC.00885.
    PubMed         Abstract available

  40. KANE A, Campbell L, Ky D, Hibbs D, et al
    The antifungal and synergistic effect of bisphosphonates in Cryptococcus.
    Antimicrob Agents Chemother. 2020 Nov 2. pii: AAC.01753.
    PubMed         Abstract available

  41. MOTOS A, Li Bassi G, Pagliara F, Fernandez-Barat L, et al
    Short-Term Effects of Appropriate Empirical Antimicrobial Treatment with Ceftolozane/Tazobactam in a Swine Model of Nosocomial Pneumonia.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  42. CHATTERJEE A, Poon R, Chatterjee SS
    Stp1 loss of function promotes beta-lactam resistance in S. aureus that is independent of classical genes.
    Antimicrob Agents Chemother. 2020 Mar 16. pii: AAC.02222.
    PubMed         Abstract available

  43. AEDO SJ, Tang J, Brynildsen MP
    Metabolites Potentiate Nitrofurans in Nongrowing Escherichia coli.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  44. SAITO S, Hayakawa K, Tsuzuki S, Ishikane M, et al
    The Impact of the Clinical Outcomes and Risk Factors of Patients with IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae in Japan: A Matched Case-Case-Control Study.
    Antimicrob Agents Chemother. 2020 Nov 30. pii: AAC.01483.
    PubMed         Abstract available

  45. JIN L, Wang R, Gao H, Wang Q, et al
    Identification of a Novel Hybrid Plasmid Encoding KPC-2 and Virulence Factors in Klebsiella pneumoniae Sequence Type 11.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  46. ORTIZ DE LA ROSA JM, Nordmann P, Poirel L
    Antioxidant molecules as a source of mitigation of antibiotic resistance genes dissemination.
    Antimicrob Agents Chemother. 2021 Mar 22. pii: AAC.02658.
    PubMed         Abstract available

  47. BABOWICZ F, LaPlante R, Mitchell C, O'Donnell JN, et al
    Impact of Accelerate Pheno and BacT/Alert Virtuo on Clinical Processes and Outcomes in Patients with Sepsis and Concurrent Gram-Negative Bacteremia.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  48. BARNES KB, Richards MI, Laws TR, Nunez A, et al
    Finafloxacin Is an Effective Treatment for Inhalational Tularemia and Plague in Mouse Models of Infection.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  49. STEWART AG, Price EP, Schabacker K, Birikmen M, et al
    Molecular epidemiology of third-generation cephalosporin-resistant Enterobacteriaceae in Southeast Queensland, Australia.
    Antimicrob Agents Chemother. 2021 Mar 29. pii: AAC.00130.
    PubMed         Abstract available

  50. HUANG HY, Wang CF, Lu PL, Tseng SP, et al
    Clinical Impact of the Revised 2019 CLSI Levofloxacin Breakpoints in Patients with Enterobacterales Bacteremia.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  51. KOVANDA LL, Sass G, Martinez M, Clemons KV, et al
    Efficacy and Associated Drug Exposures of Isavuconazole and Fluconazole in an Experimental Model of Coccidioidomycosis.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  52. LOMOVSKAYA O, Rubio-Aparicio D, Nelson K, Sun D, et al
    In Vitro Activity of the Ultrabroad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Multiple Beta-Lactam Antibiotics against Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  53. FAHEEM M, Zhang CJ, Morris MN, Pleiss J, et al
    Role of Synonymous Mutations in the Evolution of TEM beta-Lactamase Genes.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  54. SOLIMAN AM, Ramadan H, Zarad H, Sugawara Y, et al
    Coproduction of Tet(X7) Conferring High-Level Tigecycline Resistance, Fosfomycin FosA4, and Colistin Mcr-1.1 in Escherichia coli Strains from Chickens in Egypt.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  55. LIU L, Zhou X, Li B, Cheng F, et al
    In Vitro and In Vivo Activities, Absorption, Tissue Distribution, and Excretion of OBP-4, a Potential Anti-Clostridioides difficile Agent.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  56. OKOLIEGBE IN, Hijazi K, Cooper K, Ironside C, et al
    Trends of antimicrobial resistance and combination susceptibility testing of cystic fibrosis multidrug-resistant Pseudomonas aeruginosa: A ten-year update.
    Antimicrob Agents Chemother. 2021 Apr 5. pii: AAC.02483.
    PubMed         Abstract available

  57. RUBIO AM, Kline EG, Jones CE, Chen L, et al
    In Vitro Susceptibility of Multidrug-Resistant Pseudomonas aeruginosa following Treatment-Emergent Resistance to Ceftolozane-Tazobactam.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  58. QIN S, Peng J, Deng R, Peng K, et al
    Identification of Two Plasmids Coharboring Carbapenemase Genes and tmexCD1-toprJ1 in Clinical Klebsiella pneumoniae ST2667.
    Antimicrob Agents Chemother. 2021;65.
    PubMed        

  59. ZENG S, Zhang J, Sun M, Zhang X, et al
    Nitric oxide-dependent electron transport chain inhibition by the cytochrome bc1 inhibitor and pretomanid combination kills Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Jun 21:AAC0095621. doi: 10.1128/AAC.00956.
    PubMed         Abstract available

  60. KOHLHOFF S, Hammerschlag MR
    In Vitro Activity of Nafithromycin (WCK 4873) against Chlamydia pneumoniae.
    Antimicrob Agents Chemother. 2021 Jun 21:AAC0058521. doi: 10.1128/AAC.00585.
    PubMed         Abstract available

  61. GONZALEZ-JIMENEZ I, Garcia-Rubio R, Monzon S, Lucio J, et al
    Multi-resistance to non-azole fungicides in Aspergillus fumigatus TR34/L98H azole resistant isolates.
    Antimicrob Agents Chemother. 2021 Jun 21:AAC0064221. doi: 10.1128/AAC.00642.
    PubMed         Abstract available

  62. LOS-ARCOS I, Berastegui C, Martin-Gomez MT, Grau S, et al
    Nebulized Micafungin Treatment for Scopulariopsis/Microascus Tracheobronchitis in Lung Transplant Recipients.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  63. MADRID-MORALES J, Sharma A, Reveles K, Velez-Mejia C, et al
    Validation of Available Extended-Spectrum-Beta-Lactamase Clinical Scoring Models in Predicting Drug Resistance in Patients with Enteric Gram-Negative Bacteremia Treated at South Texas Veterans Health Care System.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  64. AURITI C, Goffredo BM, Ronchetti MP, Piersigilli F, et al
    High-Dose Micafungin in Neonates and Young Infants with Invasive Candidiasis: Results of a Phase 2 Study.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  65. YANG X, Ye L, Chan EW, Zhang R, et al
    Characterization of an IncFIB/IncHI1B plasmid encoding efflux pump TMexCD1-TOprJ1 in a clinical tigecycline and carbapenem-resistant Klebsiella pneumoniae strain.
    Antimicrob Agents Chemother. 2021 Jan 19. pii: AAC.02340.
    PubMed         Abstract available

  66. PENNINGS LJ, Ruth MM, Wertheim HFL, van Ingen J, et al
    The Benzimidazole SPR719 Shows Promising Concentration-Dependent Activity and Synergy against Nontuberculous Mycobacteria.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  67. LEE A, Wang N, Carter CL, Zimmerman M, et al
    Therapeutic Potential of Fosmanogepix (APX001) for Intra-abdominal Candidiasis: from Lesion Penetration to Efficacy in a Mouse Model.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  68. CHALKER VJ, Sharratt MG, Rees C, Bell OH, et al
    Tetracycline resistance mediated by tet(M) has variable Integrative Conjugative Element composition in Mycoplasma hominis isolated in the United Kingdom from 2005-2015.
    Antimicrob Agents Chemother. 2021 Jan 19. pii: AAC.02513.
    PubMed         Abstract available

  69. CHENG J, Yan J, Reyna Z, Slarve M, et al
    Synergistic Rifabutin and Colistin Reduce Emergence of Resistance When Treating Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  70. XIANG R, Li M
    Identification of Tn6835 and a Novel Genomic Island, MMGI-1, in a Pan-Resistant Morganella morganii Strain.
    Antimicrob Agents Chemother. 2021;65.
    PubMed        

  71. MAZZANTINI D, Celandroni F, Calvigioni M, Lupetti A, et al
    In Vitro Resistance and Evolution of Resistance to Tavaborole in Trichophyton rubrum.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  72. SANDARADURA I, Wojciechowski J, Marriott DJE, Day RO, et al
    Model-Optimized Fluconazole Dose Selection for Critically Ill Patients Improves Early Pharmacodynamic Target Attainment without the Need for Therapeutic Drug Monitoring.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  73. POILVACHE H, Ruiz-Sorribas A, Cornu O, Van Bambeke F, et al
    In Vitro Study of the Synergistic Effect of an Enzyme Cocktail and Antibiotics against Biofilms in a Prosthetic Joint Infection Model.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  74. DIAZ-GARCIA J, Mesquida A, Sanchez-Carrillo C, Reigadas E, et al
    Monitoring the Epidemiology and Antifungal Resistance of Yeasts Causing Fungemia in a Tertiary Care Hospital in Madrid, Spain: Any Relevant Changes in the Last 13 Years?
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  75. MASUKO A, Takata I, Fujita K, Okumura H, et al
    In Vitro and In Vivo Activities of TP0480066, a Novel Topoisomerase Inhibitor, against Neisseria gonorrhoeae.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  76. BOOT W, Schmid T, D'Este M, Guillaume O, et al
    A Hyaluronic Acid Hydrogel Loaded with Gentamicin and Vancomycin Successfully Eradicates Chronic Methicillin-Resistant Staphylococcus aureus Orthopedic Infection in a Sheep Model.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  77. NAKAMURA R, Oota M, Matsumoto S, Sato T, et al
    In Vitro Activity and In Vivo Efficacy of Cefiderocol against Stenotrophomonas maltophilia.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  78. URBANOWICZ P, Bitar I, Izdebski R, Baraniak A, et al
    Epidemic Territorial Spread of IncP-2-Type VIM-2 Carbapenemase-Encoding Megaplasmids in Nosocomial Pseudomonas aeruginosa Populations.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  79. OKA D, Yamaya N, Kuno T, Asakawa Y, et al
    In Vitro and In Vivo Antibacterial Activities of a Novel Quinolone Compound, OPS-2071, against Clostridioides difficile.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  80. ABUTALEB NS, Elkashif A, Flaherty DP, Seleem MN, et al
    In Vivo Antibacterial Activity of Acetazolamide.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  81. OUESLATI S, Emeraud C, Grosperrin V, Levy M, et al
    Polyclonal Dissemination of NDM-1- and NDM-9-Producing Escherichia coli and Klebsiella pneumoniae in French Polynesia.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available


    BMC Neurol

  82. PEREZ JALS, Espiritu AI, Jamora RDG
    Google search behavior for meningitis and its vaccines: an infodemiological study.
    BMC Neurol. 2021;21:232.
    PubMed         Abstract available


    BMJ

  83. PEREZ-LOPEZ A, Irwin A, Rodrigo C, Prat-Aymerich C, et al
    Role of C reactive protein and procalcitonin in the diagnosis of lower respiratory tract infection in children in the outpatient setting.
    BMJ. 2021;373:n1409.
    PubMed        

  84. BLANK M, Collas O, Hirji H
    A young man with shortness of breath.
    BMJ. 2021;373:n1313.
    PubMed        


    Clin Infect Dis

  85. OCHOA S, Ding L, Kreuzburg S, Treat J, et al
    Daratumumab (Anti-CD38) for Treatment of Disseminated Nontuberculous Mycobacteria in a Patient With Anti-Interferon-gamma Autoantibodies.
    Clin Infect Dis. 2021;72:2206-2208.
    PubMed         Abstract available

  86. YOUNG VB
    Unexpected Results From a Phase 2 Trial of a Microbiome Therapeutic for Clostridioides difficile Infection: Lessons for the Future.
    Clin Infect Dis. 2021;72:2141-2143.
    PubMed        

  87. REVOLINSKI S, Munoz-Price LS
    Fecal Microbiota Transplantation for Clostridioides difficile Infection in Immunocompromised Hosts.
    Clin Infect Dis. 2021;72:2247.
    PubMed        

  88. MCGOVERN BH, Ford CB, Henn MR, Pardi DS, et al
    SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial.
    Clin Infect Dis. 2021;72:2132-2140.
    PubMed         Abstract available

  89. KARLOWSKY JA, Lob SH, Raddatz J, DePestel DD, et al
    In Vitro Activity of Imipenem/Relebactam and Ceftolozane/Tazobactam Against Clinical Isolates of Gram-negative Bacilli With Difficult-to-Treat Resistance and Multidrug-resistant Phenotypes-Study for Monitoring Antimicrobial Resistance Trends, United S
    Clin Infect Dis. 2021;72:2112-2120.
    PubMed         Abstract available

  90. KOIZUMI Y, Mikamo H
    Anti-Interferon Gamma Autoantibody and Disseminated Nontuberculous Mycobacteria Infection: What Should Be Done to Improve Its Clinical Outcome?
    Clin Infect Dis. 2021;72:2209-2211.
    PubMed        

  91. METCALF BJ, Chochua S, Walker H, Tran T, et al
    Invasive Pneumococcal Strain Distributions and Isolate Clusters Associated With Persons Experiencing Homelessness During 2018.
    Clin Infect Dis. 2021;72:e948-e956.
    PubMed         Abstract available

  92. PELTON SI, Lapidot R
    Inferring public health and vaccine policies from epidemiology and whole genome sequencing of invasive pneumococcal isolates from a surveillance network.
    Clin Infect Dis. 2020 Nov 5. pii: 5957066. doi: 10.1093/cid/ciaa1688.
    PubMed        

  93. INGHAMMAR M, Svanstrom H, Voldstedlund M, Melbye M, et al
    Proton-Pump Inhibitor Use and the Risk of Community-Associated Clostridium difficile Infection.
    Clin Infect Dis. 2021;72:e1084-e1089.
    PubMed         Abstract available

  94. CEGIELSKI JP, Udwadia ZF, Viiklepp P, Yim JJ, et al
    Reply to van Deun and Decroo.
    Clin Infect Dis. 2021;72:e1168-e1169.
    PubMed        

  95. VAN DEUN A, Decroo T
    How second-line injectable drugs work.
    Clin Infect Dis. 2020 Dec 20. pii: 6042343. doi: 10.1093/cid/ciaa1874.
    PubMed        

  96. VILLAFUERTE-GALVEZ JA
    Proton Pump Inhibitors and Incident Clostridioides difficile Infection: Beyond Controversy, Pragmatic Approaches Are Needed.
    Clin Infect Dis. 2021;72:e1090-e1092.
    PubMed        

  97. CAWCUTT KA, Patel R, Gerber J, Caliendo AM, et al
    Leveraging Existing and Soon-to-Be-Available Novel Diagnostics for Optimizing Outpatient Antibiotic Stewardship in Patients With Respiratory Tract Infections.
    Clin Infect Dis. 2021;72:e1115-e1121.
    PubMed         Abstract available


    Curr Microbiol

  98. EVENHUIS JP, Lipscomb R, Birkett C
    Growth of Flavobacterium columnare Genomovars in the Presence or Lack of Supplemental Cations.
    Curr Microbiol. 2021;78:2474-2480.
    PubMed         Abstract available

  99. ASSOLINI JP, Lenhard-Vidal A, Bredt CSO, Tano ZN, et al
    Distinct Pattern of Paracoccidioides lutzii, P. restrepiensis and P. americana Antigens Recognized by IgE in Human Paracoccidioidomycosis.
    Curr Microbiol. 2021;78:2608-2614.
    PubMed         Abstract available

  100. HOSSAIN ZZ, Sultana R, Begum A, Jensen PKM, et al
    Investigation of the Domestic Reservoirs of Diarrheagenic Escherichia coli in Diarrhea Case Households of Urban Bangladesh.
    Curr Microbiol. 2021;78:2534-2547.
    PubMed         Abstract available


    Diagn Microbiol Infect Dis

  101. OLDBERG K, Rasmussen M
    Enterococcus faecalis in blood cultures-a prospective study on the role of persistent bacteremia.
    Diagn Microbiol Infect Dis. 2021;101:115433.
    PubMed         Abstract available


    Eur J Clin Microbiol Infect Dis

  102. ARGUDIN MA, Deplano A, Nonhoff C, Yin N, et al
    Epidemiology of the Staphylococcus aureus CA-MRSA USA300 in Belgium.
    Eur J Clin Microbiol Infect Dis. 2021 Jun 23. pii: 10.1007/s10096-021-04286.
    PubMed         Abstract available


    Infect Immun

  103. GRILLOVA L, Musilova J, Janeckova K, Pospisilova P, et al
    The Arg753Gln polymorphism of Toll-like receptor 2 has a lower occurrence in patients with syphilis suggesting its protective effect in Czech and Slovak individuals.
    Infect Immun. 2020 Oct 19. pii: IAI.00503-20. doi: 10.1128/IAI.00503.
    PubMed         Abstract available


    J Antimicrob Chemother

  104. DAI VTT, Beissbarth J, Thanh PV, Hoan PT, et al
    Hospital surveillance predicts community pneumococcal antibiotic resistance in Vietnam.
    J Antimicrob Chemother. 2020 Jul 29. pii: 5878176. doi: 10.1093.
    PubMed         Abstract available

  105. STEWART AG, Harris PNA, Henderson A, Schembri MA, et al
    Oral cephalosporin and beta-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections.
    J Antimicrob Chemother. 2020 May 22. pii: 5842233. doi: 10.1093.
    PubMed         Abstract available

  106. LAM TT, Nurnberg S, Claus H, Vogel U, et al
    Molecular epidemiology of imipenem resistance in invasive Haemophilus influenzae infections in Germany in 2016.
    J Antimicrob Chemother. 2020 May 25. pii: 5843865. doi: 10.1093.
    PubMed         Abstract available

  107. SEIFERT H, Muller C, Stefanik D, Higgins PG, et al
    In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumannii.
    J Antimicrob Chemother. 2020 Jun 9. pii: 5855123. doi: 10.1093.
    PubMed         Abstract available

  108. CAO T, Liu Y, Li Y, Wang Y, et al
    A public health concern: emergence of carbapenem-resistant Klebsiella pneumoniae in a public transportation environment.
    J Antimicrob Chemother. 2020 Jul 4. pii: 5867249. doi: 10.1093.
    PubMed         Abstract available

  109. RIVAYA B, Jordana-Lluch E, Fernandez-Rivas G, Molinos S, et al
    Macrolide resistance and molecular typing of Mycoplasma pneumoniae infections during a 4 year period in Spain.
    J Antimicrob Chemother. 2020 Jul 12. pii: 5870410. doi: 10.1093.
    PubMed         Abstract available

  110. ZHANG S, Wang X, Wise MJ, He Y, et al
    Mutations of Helicobacter pylori RdxA are mainly related to the phylogenetic origin of the strain and not to metronidazole resistance.
    J Antimicrob Chemother. 2020 Jul 17. pii: 5872801. doi: 10.1093.
    PubMed         Abstract available

  111. CHAN AP, Choi Y, Clarke TH, Brinkac LM, et al
    AbGRI4, a novel antibiotic resistance island in multiply antibiotic-resistant Acinetobacter baumannii clinical isolates.
    J Antimicrob Chemother. 2020 Jul 18. pii: 5873331. doi: 10.1093.
    PubMed         Abstract available

  112. LI Y, Xiu L, Liu J, Zhang C, et al
    A multiplex assay for characterization of antimicrobial resistance in Neisseria gonorrhoeae using multi-PCR coupled with mass spectrometry.
    J Antimicrob Chemother. 2020 Jul 20. pii: 5874078. doi: 10.1093.
    PubMed         Abstract available

  113. DE LASTOURS V, Laouenan C, Royer G, Carbonnelle E, et al
    Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it.
    J Antimicrob Chemother. 2020 May 17. pii: 5838343. doi: 10.1093.
    PubMed         Abstract available

  114. MARTINEZ EP, van Rosmalen J, Bustillos R, Natsch S, et al
    Trends, seasonality and the association between outpatient antibiotic use and antimicrobial resistance among urinary bacteria in the Netherlands.
    J Antimicrob Chemother. 2020 May 17. pii: 5838345. doi: 10.1093.
    PubMed         Abstract available

  115. CHANAME PINEDO LE, Bruyndonckx R, Catry B, Latour K, et al
    Fluoroquinolone resistance in Escherichia coli isolates after exposure to non-fluoroquinolone antibiotics: a retrospective case-control study.
    J Antimicrob Chemother. 2020 May 12. pii: 5836063. doi: 10.1093.
    PubMed         Abstract available

  116. LESTER R, Musicha P, van Ginneken N, Dramowski A, et al
    Prevalence and outcome of bloodstream infections due to third-generation cephalosporin-resistant Enterobacteriaceae in sub-Saharan Africa: a systematic review.
    J Antimicrob Chemother. 2019 Nov 19. pii: 5632029. doi: 10.1093.
    PubMed         Abstract available

  117. HAYAKAWA K, Nakano R, Hase R, Shimatani M, et al
    Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae.
    J Antimicrob Chemother. 2019 Dec 2. pii: 5650359. doi: 10.1093.
    PubMed         Abstract available

  118. LO SW, Gladstone RA, van Tonder AJ, Du Plessis M, et al
    A mosaic tetracycline resistance gene tet(S/M) detected in an MDR pneumococcal CC230 lineage that underwent capsular switching in South Africa.
    J Antimicrob Chemother. 2019 Dec 2. pii: 5650366. doi: 10.1093.
    PubMed         Abstract available

  119. ABBOTT IJ, Dekker J, van Gorp E, Wijma RA, et al
    Impact of bacterial species and baseline resistance on fosfomycin efficacy in urinary tract infections.
    J Antimicrob Chemother. 2019 Dec 24. pii: 5686404. doi: 10.1093.
    PubMed         Abstract available

  120. PAINSET A, Day M, Doumith M, Rigby J, et al
    Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Campylobacter jejuni and Campylobacter coli isolated from cases of diarrhoeal disease in England and Wales, 2015-16.
    J Antimicrob Chemother. 2020 Jan 16. pii: 5707358. doi: 10.1093.
    PubMed         Abstract available

  121. BOURELY C, Coeffic T, Caillon J, Thibaut S, et al
    Trends in antimicrobial resistance among Escherichia coli from defined infections in humans and animals.
    J Antimicrob Chemother. 2020 Feb 12. pii: 5734707. doi: 10.1093.
    PubMed         Abstract available

  122. LAN PT, Golparian D, Ringlander J, Van Hung L, et al
    Genomic analysis and antimicrobial resistance of Neisseria gonorrhoeae isolates from Vietnam in 2011 and 2015-16.
    J Antimicrob Chemother. 2020 Feb 18. pii: 5740025. doi: 10.1093.
    PubMed         Abstract available

  123. ROHDE AM, Zweigner J, Wiese-Posselt M, Schwab F, et al
    Prevalence of third-generation cephalosporin-resistant Enterobacterales colonization on hospital admission and ESBL genotype-specific risk factors: a cross-sectional study in six German university hospitals.
    J Antimicrob Chemother. 2020 Mar 16. pii: 5805542. doi: 10.1093.
    PubMed         Abstract available

  124. ABBOTT IJ, van Gorp E, Wijma RA, Dekker J, et al
    Efficacy of single and multiple oral doses of fosfomycin against Pseudomonas aeruginosa urinary tract infections in a dynamic in vitro bladder infection model.
    J Antimicrob Chemother. 2020 May 3. pii: 5828355. doi: 10.1093.
    PubMed         Abstract available

  125. GOLPARIAN D, Bazzo ML, Golfetto L, Gaspar PC, et al
    Genomic epidemiology of Neisseria gonorrhoeae elucidating the gonococcal antimicrobial resistance and lineages/sublineages across Brazil, 2015-16.
    J Antimicrob Chemother. 2020 Aug 12. pii: 5891806. doi: 10.1093.
    PubMed         Abstract available

  126. LYU T, Cheung KS, Ni L, Guo J, et al
    High prevalence and risk factors of multiple antibiotic resistance in patients who fail first-line Helicobacter pylori therapy in southern China: a municipality-wide, multicentre, prospective cohort study.
    J Antimicrob Chemother. 2020 Aug 12. pii: 5891805. doi: 10.1093.
    PubMed         Abstract available

  127. DIACONU EL, Carfora V, Alba P, Di Matteo P, et al
    Novel IncFII plasmid harbouring blaNDM-4 in a carbapenem-resistant Escherichia coli of pig origin, Italy.
    J Antimicrob Chemother. 2020 Aug 24. pii: 5896583. doi: 10.1093.
    PubMed         Abstract available

  128. ARA-MONTOJO MF, Escosa-Garcia L, Alguacil-Guillen M, Seara N, et al
    Predictors of mortality and clinical characteristics among carbapenem-resistant or carbapenemase-producing Enterobacteriaceae bloodstream infections in Spanish children.
    J Antimicrob Chemother. 2020 Oct 10. pii: 5920733. doi: 10.1093.
    PubMed         Abstract available

  129. KHANINA A, Urbancic KF, Haeusler GM, Kong DCM, et al
    Establishing essential metrics for antifungal stewardship in hospitals: the results of an international Delphi survey.
    J Antimicrob Chemother. 2021;76:253-262.
    PubMed         Abstract available

  130. DUGGETT N, Ellington MJ, Hopkins KL, Ellaby N, et al
    Detection in livestock of the human pandemic Escherichia coli ST131 fimH30(R) clone carrying blaCTX-M-27.
    J Antimicrob Chemother. 2021;76:263-265.
    PubMed        

  131. GUIRAUD J, Lounnas M, Boissiere A, Le Roy C, et al
    Lower mgpB diversity in macrolide-resistant Mycoplasma genitalium infecting men visiting two sexually transmitted infection clinics in Montpellier, France.
    J Antimicrob Chemother. 2020 Oct 20. pii: 5930856. doi: 10.1093.
    PubMed         Abstract available

  132. ARCA-SUAREZ J, Lasarte-Monterrubio C, Rodino-Janeiro BK, Cabot G, et al
    Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections.
    J Antimicrob Chemother. 2021;76:91-100.
    PubMed         Abstract available

  133. BEZABIH YM, Sabiiti W, Alamneh E, Bezabih A, et al
    The global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli in the community.
    J Antimicrob Chemother. 2021;76:22-29.
    PubMed         Abstract available

  134. PINHOLT M, Mollerup S, Boye K, Worning P, et al
    Investigation of the introduction and dissemination of vanB Enterococcus faecium in the Capital Region of Denmark and development of a rapid and accurate clone-specific vanB E. faecium PCR.
    J Antimicrob Chemother. 2021 Jun 21. pii: 6306968. doi: 10.1093.
    PubMed         Abstract available

  135. SATISHKUMAR N, Alexander JAN, Poon R, Buggeln E, et al
    PBP4-mediated beta-lactam resistance among clinical strains of Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Jun 21. pii: 6307153. doi: 10.1093.
    PubMed         Abstract available

  136. KRUGER H, Ji X, Wang Y, Fessler AT, et al
    Identification of Tn553, a novel Tn554-related transposon that carries a complete blaZ-blaR1-blaI beta-lactamase operon in Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Jun 24. pii: 6308652. doi: 10.1093.
    PubMed        

  137. PEREZ-VISO B, Hernandez-Garcia M, Ponce-Alonso M, Morosini MI, et al
    Characterization of carbapenemase-producing Serratia marcescens and whole-genome sequencing for plasmid typing in a hospital in Madrid, Spain (2016-18).
    J Antimicrob Chemother. 2021;76:110-116.
    PubMed         Abstract available

  138. TREMBIZKI E, Jennison AV, Buckley C, Bright A, et al
    Enhanced molecular surveillance in response to the detection of extensively resistant gonorrhoea in Australia.
    J Antimicrob Chemother. 2021;76:270-271.
    PubMed        

  139. LOUKA C, Ravensbergen SJ, Ott A, Zhou X, et al
    Predominance of CTX-M-15-producing ST131 strains among ESBL-producing Escherichia coli isolated from asylum seekers in the Netherlands.
    J Antimicrob Chemother. 2021;76:70-76.
    PubMed         Abstract available

  140. RICHELSEN R, Smit J, Schonheyder HC, Laxsen Anru P, et al
    Outcome of community-onset ESBL-producing Escherichia coli and Klebsiella pneumoniae bacteraemia and urinary tract infection: a population-based cohort study in Denmark.
    J Antimicrob Chemother. 2020 Aug 30. pii: 5899248. doi: 10.1093.
    PubMed         Abstract available

  141. AMBROSE SJ, Hall RM
    A novel trimethoprim resistance gene, dfrA38, found in a sporadic Acinetobacter baumannii isolate.
    J Antimicrob Chemother. 2020 Sep 15. pii: 5905668. doi: 10.1093.
    PubMed        

  142. ROUX J, Nekkab N, Colomb-Cotinat M, Astagneau P, et al
    Time-series modelling for the quantification of seasonality and forecasting antibiotic-resistant episodes: application to carbapenemase-producing Enterobacteriaceae episodes in France over 2010-20.
    J Antimicrob Chemother. 2020 Sep 15. pii: 5905635. doi: 10.1093.
    PubMed         Abstract available

  143. HADAD R, Cole MJ, Ebeyan S, Jacobsson S, et al
    Evaluation of the SpeeDx ResistancePlus(R) GC and SpeeDx GC 23S 2611 (beta) molecular assays for prediction of antimicrobial resistance/susceptibility to ciprofloxacin and azithromycin in Neisseria gonorrhoeae.
    J Antimicrob Chemother. 2020 Sep 15. pii: 5905664. doi: 10.1093.
    PubMed         Abstract available

  144. BUCKLEY AM, Altringham J, Clark E, Bently K, et al
    Eravacycline, a novel tetracycline derivative, does not induce Clostridioides difficile infection in an in vitro human gut model.
    J Antimicrob Chemother. 2021;76:171-178.
    PubMed         Abstract available

  145. ABBOTSFORD J, Foley DA, Goff Z, Bowen AC, et al
    Clinical experience with SUBA-itraconazole at a tertiary paediatric hospital.
    J Antimicrob Chemother. 2021;76:249-252.
    PubMed         Abstract available

  146. KUMWENDA GP, Sugawara Y, Akeda Y, Matsumoto Y, et al
    Genomic features of plasmids coding for KPC-2, NDM-5 or OXA-48 carbapenemases in Enterobacteriaceae from Malawi.
    J Antimicrob Chemother. 2021;76:267-270.
    PubMed        

  147. TANG Y, Lai Y, Kong L, Wang X, et al
    Characterization of three porcine Escherichia coli isolates co-harbouring tet(X4) and cfr.
    J Antimicrob Chemother. 2021;76:263-264.
    PubMed        

  148. BOEL JB, Antsupova V, Knudsen JD, Jarlov JO, et al
    Intravenous mecillinam compared with other beta-lactams as targeted treatment for Escherichia coli or Klebsiella spp. bacteraemia with urinary tract focus.
    J Antimicrob Chemother. 2021;76:206-211.
    PubMed         Abstract available


    J Bacteriol

  149. LEE SF, Li L, Jalal N, Halperin SA, et al
    Identification of a Thiol-Disulfide Oxidoreductase (SdbA) catalyzing Disulfide Bond Formation in the Superantigen SpeA in Streptococcus pyogenes.
    J Bacteriol. 2021 Jun 21:JB0015321. doi: 10.1128/JB.00153.
    PubMed         Abstract available


    J Clin Microbiol

  150. LEAL SM JR, Totten AH, Xiao L, Crabb DM, et al
    Evaluation of Commercial Molecular Diagnostic Methods for the Detection and Determination of Macrolide Resistance in Mycoplasma pneumoniae.
    J Clin Microbiol. 2020 Apr 8. pii: JCM.00242-20. doi: 10.1128/JCM.00242.
    PubMed         Abstract available

  151. RAKOVITSKY N, Frenk S, Kon H, Schwartz D, et al
    FT-IR Spectroscopy is a New Option for Outbreak Investigation: A Retrospective Analysis of an ESBL-producing Klebsiella pneumoniae Outbreak in a Neonatal Intensive Care Unit.
    J Clin Microbiol. 2020 Mar 11. pii: JCM.00098-20. doi: 10.1128/JCM.00098.
    PubMed         Abstract available

  152. CHAPMAN P, Forde BM, Roberts LW, Bergh H, et al
    Genomic investigation reveals contaminated detergent as the source of an ESBL-producing Klebsiella michiganensis outbreak in a neonatal unit.
    J Clin Microbiol. 2020 Feb 26. pii: JCM.01980-19. doi: 10.1128/JCM.01980.
    PubMed         Abstract available

  153. KERSH EN, Pham CD, Papp JR, Myers R, et al
    Expanding US Laboratory Capacity for Neisseria gonorrhoeae Antimicrobial Susceptibility Testing and Whole Genome Sequencing through CDC's Antibiotic Resistance Laboratory Network.
    J Clin Microbiol. 2020 Feb 5. pii: JCM.01461-19. doi: 10.1128/JCM.01461.
    PubMed         Abstract available

  154. PICHON M, Pichard B, Barrioz T, Plouzeau C, et al
    Diagnostic accuracy of a non-invasive test for the detection of Helicobacter pylori and resistance to clarithromycin in stool by Real-Time PCR Amplidiag((R)) H. pylori + ClariR assay.
    J Clin Microbiol. 2020 Jan 29. pii: JCM.01787-19. doi: 10.1128/JCM.01787.
    PubMed         Abstract available

  155. DOWNES KJ, Fitzgerald JC, Weiss SL
    Utility of Procalcitonin as a Biomarker for Sepsis in Children.
    J Clin Microbiol. 2020 Apr 29. pii: JCM.01851-19. doi: 10.1128/JCM.01851.
    PubMed         Abstract available

  156. SWEENEY EL, Tickner J, Bletchly C, Nimmo GR, et al
    Genotyping of Mycoplasma genitalium suggests de novo acquisition of antimicrobial resistance, Queensland, Australia.
    J Clin Microbiol. 2020 Jun 3. pii: JCM.00641-20. doi: 10.1128/JCM.00641.
    PubMed         Abstract available

  157. BURNARD D, Gore L, Henderson A, Ranasinghe A, et al
    Comparative genomics and antimicrobial resistance profiling of Elizabethkingia isolates reveals nosocomial transmission and in vitro susceptibility to fluoroquinolones, tetracyclines and trimethoprim-sulfamethoxazole.
    J Clin Microbiol. 2020 Jun 24. pii: JCM.00730-20. doi: 10.1128/JCM.00730.
    PubMed         Abstract available

  158. HILMARSDOTTIR I, Arnardottir EM, Johannesdottir ER, Valsdottir F, et al
    Prevalence of Mycoplasma genitalium and antibiotic resistance-associated mutations in an Icelandic STI population, and comparison of the S-DiaMGTV and Aptima Mycoplasma genitalium assays for diagnosis.
    J Clin Microbiol. 2020 Jul 1. pii: JCM.01084-20. doi: 10.1128/JCM.01084.
    PubMed         Abstract available

  159. JOSEPH LA, Francois Watkins LK, Chen J, Tagg KA, et al
    Comparison of Molecular Subtyping and Antimicrobial Resistance Detection Methods Used in a Large Multi-State Outbreak of Extensively Drug-Resistant Campylobacter jejuni Infections Linked to Pet Store Puppies.
    J Clin Microbiol. 2020 Jul 22. pii: JCM.00771-20. doi: 10.1128/JCM.00771.
    PubMed         Abstract available

  160. SWEENEY EL, Lowry K, Ebeyan S, Lundgren M, et al
    Evaluation of the SpeeDx MG parC (beta) PCR assay for the rapid detection of Mycoplasma genitalium quinolone resistance-associated mutations.
    J Clin Microbiol. 2020 Jul 22. pii: JCM.01432-20. doi: 10.1128/JCM.01432.
    PubMed         Abstract available

  161. DIPPENAAR A, Goossens SN, Grobbelaar M, Oostvogels S, et al
    Nanopore sequencing for Mycobacterium tuberculosis: a critical review of the literature, new developments and future opportunities.
    J Clin Microbiol. 2021 Jun 16:JCM0064621. doi: 10.1128/JCM.00646.
    PubMed         Abstract available


    J Immunol

  162. LARSON EC, Ellis-Connell A, Rodgers MA, Balgeman AJ, et al
    Pre-existing Simian Immunodeficiency Virus Infection Increases Expression of T Cell Markers Associated with Activation during Early Mycobacterium tuberculosis Coinfection and Impairs TNF Responses in Granulomas.
    J Immunol. 2021 Jun 18. pii: jimmunol.2100073. doi: 10.4049/jimmunol.2100073.
    PubMed         Abstract available


    J Infect Dis

  163. LI Z, Beesetty P, Gerges G, Kleinhenz M, et al
    Impaired T lymphocyte responses during childhood Staphylococcus aureus infection.
    J Infect Dis. 2021 Jun 19. pii: 6305612. doi: 10.1093.
    PubMed         Abstract available


    J Med Chem

  164. VAN DER WESTHUYZEN R, Mabhula A, Njaria PM, Muller R, et al
    Benzoheterocyclic Oxime Carbamates Active against Mycobacterium tuberculosis: Synthesis, Structure-Activity Relationship, Metabolism, and Biology Triaging.
    J Med Chem. 2021 Jun 17. doi: 10.1021/acs.jmedchem.1c00707.
    PubMed         Abstract available

  165. WANG Z, Li J, Benin BM, Yu B, et al
    Lipophilic Ga Complex with Broad-Spectrum Antimicrobial Activity and the Ability to Overcome Gallium Resistance in both Pseudomonas aeruginosa and Staphylococcus aureus.
    J Med Chem. 2021 Jun 17. doi: 10.1021/acs.jmedchem.1c00656.
    PubMed         Abstract available

  166. NACLERIO GA, Sintim HO
    Starving Bacteria of Iron: A Potential Strategy to Disperse Bacterial Biofilms.
    J Med Chem. 2021;64:7272-7274.
    PubMed         Abstract available

  167. KEOUGH DT, Wun SJ, Baszczynski O, Eng WS, et al
    Helicobacter pylori Xanthine-Guanine-Hypoxanthine Phosphoribosyltransferase-A Putative Target for Drug Discovery against Gastrointestinal Tract Infections.
    J Med Chem. 2021;64:5710-5729.
    PubMed         Abstract available

  168. YANG H, Kundra S, Chojnacki M, Liu K, et al
    A Modular Synthetic Route Involving N-Aryl-2-nitrosoaniline Intermediates Leads to a New Series of 3-Substituted Halogenated Phenazine Antibacterial Agents.
    J Med Chem. 2021;64:7275-7295.
    PubMed         Abstract available


    JAMA

  169. UYEKI TM, Wentworth DE, Jernigan DB
    Influenza Activity in the US During the 2020-2021 Season.
    JAMA. 2021 May 24. pii: 2780518. doi: 10.1001/jama.2021.6125.
    PubMed        


    MMWR Morb Mortal Wkly Rep

  170. VASSER M, Barkley J, Miller A, Gee E, et al
    Notes from the Field: Multistate Outbreak of Escherichia coli O26 Infections Linked to Raw Flour - United States, 2019.
    MMWR Morb Mortal Wkly Rep. 2021;70:600-601.
    PubMed        


    N Engl J Med

  171. LAU A, Kong FYS, Fairley CK, Templeton DJ, et al
    Azithromycin or Doxycycline for Asymptomatic Rectal Chlamydia trachomatis.
    N Engl J Med. 2021;384:2418-2427.
    PubMed         Abstract available

  172. ROTHENBERG ME
    An Allergic Basis for Abdominal Pain.
    N Engl J Med. 2021;384:2156-2158.
    PubMed        

  173. TAPIA MD, Sow SO, Naficy A, Diallo F, et al
    Meningococcal Serogroup ACWYX Conjugate Vaccine in Malian Toddlers.
    N Engl J Med. 2021;384:2115-2123.
    PubMed         Abstract available


    Nat Med

  174. PROCTOR DM, Dangana T, Sexton DJ, Fukuda C, et al
    Integrated genomic, epidemiologic investigation of Candida auris skin colonization in a skilled nursing facility.
    Nat Med. 2021 Jun 21. pii: 10.1038/s41591-021-01383.
    PubMed         Abstract available


    Nature

  175. WARNAT-HERRESTHAL S, Schultze H, Shastry KL, Manamohan S, et al
    Swarm Learning for decentralized and confidential clinical machine learning.
    Nature. 2021 May 26. pii: 10.1038/s41586-021-03583.
    PubMed         Abstract available


    PLoS Negl Trop Dis

  176. DINHUZEN J, Limothai U, Tachaboon S, Krairojananan P, et al
    A prospective study to evaluate the accuracy of rapid diagnostic tests for diagnosis of human leptospirosis: Result from THAI-LEPTO AKI study.
    PLoS Negl Trop Dis. 2021;15:e0009159.
    PubMed         Abstract available

  177. MENDOZA-ROLDAN JA, Ravindran Santhakumari Manoj R, Latrofa MS, Iatta R, et al
    Role of reptiles and associated arthropods in the epidemiology of rickettsioses: A one health paradigm.
    PLoS Negl Trop Dis. 2021;15:e0009090.
    PubMed         Abstract available

  178. TREVINO SR, Dankmeyer JL, Fetterer DP, Klimko CP, et al
    Comparative virulence of three different strains of Burkholderia pseudomallei in an aerosol non-human primate model.
    PLoS Negl Trop Dis. 2021;15:e0009125.
    PubMed         Abstract available

  179. ZEMINIAN DE OLIVEIRA LB, Della Coletta AM, Gardizani TP, Barrozo LV, et al
    Paracoccidioimycosis and white individuals: Susceptibility and biogeographic aspects in an important endemic area in Brazil.
    PLoS Negl Trop Dis. 2021;15:e0009086.
    PubMed         Abstract available

  180. SANTOS MMD, Rosendo TMSS, Lopes AKB, Roncalli AG, et al
    Weaknesses in primary health care favor the growth of acquired syphilis.
    PLoS Negl Trop Dis. 2021;15:e0009085.
    PubMed         Abstract available

  181. MUNYUA P, Osoro E, Hunsperger E, Ngere I, et al
    High incidence of human brucellosis in a rural Pastoralist community in Kenya, 2015.
    PLoS Negl Trop Dis. 2021;15:e0009049.
    PubMed         Abstract available

  182. CHEN X, Munoz B, Mkocha H, Wolle MA, et al
    Children as messengers of health knowledge? Impact of health promotion and water infrastructure in schools on facial cleanliness and trachoma in the community.
    PLoS Negl Trop Dis. 2021;15:e0009119.
    PubMed         Abstract available

  183. KUBICEK-SUTHERLAND JZ, Xie G, Shakya M, Dighe PK, et al
    Comparative genomic and phenotypic characterization of invasive non-typhoidal Salmonella isolates from Siaya, Kenya.
    PLoS Negl Trop Dis. 2021;15:e0008991.
    PubMed         Abstract available

  184. TAAL AT, Blok DJ, van Brakel WH, de Vlas SJ, et al
    Number of people requiring post-exposure prophylaxis to end leprosy: A modeling study.
    PLoS Negl Trop Dis. 2021;15:e0009146.
    PubMed         Abstract available

  185. DAY CJ, Roltgen K, Pluschke G, Jennings MP, et al
    The cell surface protein MUL_3720 confers binding of the skin pathogen Mycobacterium ulcerans to sulfated glycans and keratin.
    PLoS Negl Trop Dis. 2021;15:e0009136.
    PubMed         Abstract available

  186. NANJAN CHANDRAN SL, Tiwari A, Lustosa AA, Demir B, et al
    Revised estimates of leprosy disability weights for assessing the global burden of disease: A systematic review and individual patient data meta-analysis.
    PLoS Negl Trop Dis. 2021;15:e0009209.
    PubMed         Abstract available

  187. BRAVO V, Katz A, Porte L, Weitzel T, et al
    Genomic analysis of the diversity, antimicrobial resistance and virulence potential of clinical Campylobacter jejuni and Campylobacter coli strains from Chile.
    PLoS Negl Trop Dis. 2021;15:e0009207.
    PubMed         Abstract available

  188. GONG QL, Chen Y, Tian T, Wen X, et al
    Prevalence of bovine tuberculosis in dairy cattle in China during 2010-2019: A systematic review and meta-analysis.
    PLoS Negl Trop Dis. 2021;15:e0009502.
    PubMed         Abstract available

  189. SHUI TJ, Long H, Xiong L, Zhang XH, et al
    Towards the elimination of leprosy in Yunnan, China: A time-series analysis of surveillance data.
    PLoS Negl Trop Dis. 2021;15:e0009201.
    PubMed         Abstract available

  190. SIEROCKI R, Jneid B, Orsini Delgado ML, Plaisance M, et al
    An antibody targeting type III secretion system induces broad protection against Salmonella and Shigella infections.
    PLoS Negl Trop Dis. 2021;15:e0009231.
    PubMed         Abstract available

  191. DA SILVA PHL, de Castro KKG, Mendes MA, Calvo TL, et al
    Increased oxidative stress in elderly leprosy patients is related to age but not to bacillary load.
    PLoS Negl Trop Dis. 2021;15:e0009214.
    PubMed         Abstract available

  192. SIMPSON H, Tabah EN, Phillips RO, Frimpong M, et al
    Mapping suitability for Buruli ulcer at fine spatial scales across Africa: A modelling study.
    PLoS Negl Trop Dis. 2021;15:e0009157.
    PubMed         Abstract available

  193. COSTA F, Zeppelini CG, Ribeiro GS, Santos N, et al
    Household rat infestation in urban slum populations: Development and validation of a predictive score for leptospirosis.
    PLoS Negl Trop Dis. 2021;15:e0009154.
    PubMed         Abstract available


    PLoS One

  194. MOHIDEM NA, Osman M, Hashim Z, Muharam FM, et al
    Association of sociodemographic and environmental factors with spatial distribution of tuberculosis cases in Gombak, Selangor, Malaysia.
    PLoS One. 2021;16:e0252146.
    PubMed         Abstract available

  195. ALVES AFF, Miranda JRA, Reis F, Oliveira AA, et al
    Automatic algorithm for quantifying lung involvement in patients with chronic obstructive pulmonary disease, infection with SARS-CoV-2, paracoccidioidomycosis and no lung disease patients.
    PLoS One. 2021;16:e0251783.
    PubMed         Abstract available

  196. HOLM MKA, Winther TN, Kammann S, Rasmusson MS, et al
    Prevalence of MRSA nasal carriage among pregnant women in Copenhagen.
    PLoS One. 2021;16:e0246343.
    PubMed         Abstract available

  197. RODGERS LR, Streeter AJ, Lin N, Hamilton W, et al
    Impact of influenza vaccination on amoxicillin prescriptions in older adults: A retrospective cohort study using primary care data.
    PLoS One. 2021;16:e0246156.
    PubMed         Abstract available

  198. LIU M, Zhang W, Yao J, Niu J, et al
    Production, purification, characterization, and biological properties of Rhodosporidium paludigenum polysaccharide.
    PLoS One. 2021;16:e0246148.
    PubMed         Abstract available

  199. GETANEH DK, Hordofa LO, Ayana DA, Tessema TS, et al
    Prevalence of Escherichia coli O157:H7 and associated factors in under-five children in Eastern Ethiopia.
    PLoS One. 2021;16:e0246024.
    PubMed         Abstract available

  200. HLASHWAYO DF, Sigauque B, Noormahomed EV, Afonso SMS, et al
    A systematic review and meta-analysis reveal that Campylobacter spp. and antibiotic resistance are widespread in humans in sub-Saharan Africa.
    PLoS One. 2021;16:e0245951.
    PubMed         Abstract available

  201. BOBA A, Kostyn K, Kozak B, Zalewski I, et al
    Transcriptomic profiling of susceptible and resistant flax seedlings after Fusarium oxysporum lini infection.
    PLoS One. 2021;16:e0246052.
    PubMed         Abstract available

  202. CHAI J, Wang Q, Qin B, Wang S, et al
    Association of NOS2A gene polymorphisms with susceptibility to bovine tuberculosis in Chinese Holstein cattle.
    PLoS One. 2021;16:e0253339.
    PubMed         Abstract available

  203. INOUE K, Kashima S
    Association of the past epidemic of Mycobacterium tuberculosis with mortality and incidence of COVID-19.
    PLoS One. 2021;16:e0253169.
    PubMed         Abstract available

  204. PAN SW, Su WJ, Chan YJ, Chuang FY, et al
    Mycobacterium tuberculosis-derived circulating cell-free DNA in patients with pulmonary tuberculosis and persons with latent tuberculosis infection.
    PLoS One. 2021;16:e0253879.
    PubMed         Abstract available

  205. AGGARWAL AN, Agarwal R, Dhooria S, Prasad KT, et al
    Comparative accuracy of pleural fluid unstimulated interferon-gamma and adenosine deaminase for diagnosing pleural tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253525.
    PubMed         Abstract available

  206. REGASA DADI B, Solomon Z, Tesfaye M
    Vancomycin resistant Enterococci and its associated factors among HIV infected patients on anti-retroviral therapy in Ethiopia.
    PLoS One. 2021;16:e0251727.
    PubMed         Abstract available

  207. YU G, Shen Y, Ye B, Shi Y, et al
    Diagnostic accuracy of Mycobacterium tuberculosis cell-free DNA for tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253658.
    PubMed         Abstract available

  208. RAHMAN S, Wathington D, Waterboer T, Pawlita M, et al
    Seroprevalence of Chlamydia trachomatis, herpes simplex 2, Epstein-Barr virus, hepatitis C and associated factors among a cohort of men ages 18-70 years from three countries.
    PLoS One. 2021;16:e0253005.
    PubMed         Abstract available

  209. KATHAMUTHU GR, Moideen K, Sridhar R, Baskaran D, et al
    Reduced neutrophil granular proteins and post-treatment modulation in tuberculous lymphadenitis.
    PLoS One. 2021;16:e0253534.
    PubMed         Abstract available


    PLoS Pathog

  210. CARTER ED, Bletz MC, Le Sage M, LaBumbard B, et al
    Winter is coming-Temperature affects immune defenses and susceptibility to Batrachochytrium salamandrivorans.
    PLoS Pathog. 2021;17:e1009234.
    PubMed         Abstract available

  211. BOYLE WK, Richards CL, Dulebohn DP, Zalud AK, et al
    DksA-dependent regulation of RpoS contributes to Borrelia burgdorferi tick-borne transmission and mammalian infectivity.
    PLoS Pathog. 2021;17:e1009072.
    PubMed         Abstract available

  212. BARNIER JP, Euphrasie D, Join-Lambert O, Audry M, et al
    Type IV pilus retraction enables sustained bacteremia and plays a key role in the outcome of meningococcal sepsis in a humanized mouse model.
    PLoS Pathog. 2021;17:e1009299.
    PubMed         Abstract available

  213. JUNG HJ, Sorbara MT, Pamer EG
    TAM mediates adaptation of carbapenem-resistant Klebsiella pneumoniae to antimicrobial stress during host colonization and infection.
    PLoS Pathog. 2021;17:e1009309.
    PubMed         Abstract available

  214. TALYANSKY Y, Nielsen TB, Yan J, Carlino-Macdonald U, et al
    Capsule carbohydrate structure determines virulence in Acinetobacter baumannii.
    PLoS Pathog. 2021;17:e1009291.
    PubMed         Abstract available

  215. WARR AR, Kuehl CJ, Waldor MK
    Shiga toxin remodels the intestinal epithelial transcriptional response to Enterohemorrhagic Escherichia coli.
    PLoS Pathog. 2021;17:e1009290.
    PubMed         Abstract available

  216. RODRIGUEZ-GARCIA C, Heerman MC, Cook SC, Evans JD, et al
    Transferrin-mediated iron sequestration suggests a novel therapeutic strategy for controlling Nosema disease in the honey bee, Apis mellifera.
    PLoS Pathog. 2021;17:e1009270.
    PubMed         Abstract available

  217. CHOWDHURY R, Pavinski Bitar PD, Keresztes I, Condo AM Jr, et al
    A diffusible signal factor of the intestine dictates Salmonella invasion through its direct control of the virulence activator HilD.
    PLoS Pathog. 2021;17:e1009357.
    PubMed         Abstract available

  218. BATTU A, Purushotham R, Dey P, Vamshi SS, et al
    An aspartyl protease-mediated cleavage regulates structure and function of a flavodoxin-like protein and aids oxidative stress survival.
    PLoS Pathog. 2021;17:e1009355.
    PubMed         Abstract available

  219. CHEUNG GYC, Bae JS, Liu R, Hunt RL, et al
    Bacterial virulence plays a crucial role in MRSA sepsis.
    PLoS Pathog. 2021;17:e1009369.
    PubMed         Abstract available

  220. CHAGNEAU CV, Massip C, Bossuet-Greif N, Fremez C, et al
    Uropathogenic E. coli induces DNA damage in the bladder.
    PLoS Pathog. 2021;17:e1009310.
    PubMed         Abstract available

  221. WANG X, Zhang C, Wang S, Rashu R, et al
    SND1 promotes Th1/17 immunity against chlamydial lung infection through enhancing dendritic cell function.
    PLoS Pathog. 2021;17:e1009295.
    PubMed         Abstract available

  222. GENESTET C, Hodille E, Barbry A, Berland JL, et al
    Rifampicin exposure reveals within-host Mycobacterium tuberculosis diversity in patients with delayed culture conversion.
    PLoS Pathog. 2021;17:e1009643.
    PubMed         Abstract available

  223. CASSELLI T, Divan A, Vomhof-DeKrey EE, Tourand Y, et al
    A murine model of Lyme disease demonstrates that Borrelia burgdorferi colonizes the dura mater and induces inflammation in the central nervous system.
    PLoS Pathog. 2021;17:e1009256.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  224. ARAGAW WW, Lee BM, Yang X, Zimmerman MD, et al
    Potency boost of a Mycobacterium tuberculosis dihydrofolate reductase inhibitor by multienzyme F420H2-dependent reduction.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


    Science

  225. SHATALIN K, Nuthanakanti A, Kaushik A, Shishov D, et al
    Inhibitors of bacterial H2S biogenesis targeting antibiotic resistance and tolerance.
    Science. 2021;372:1169-1175.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: